EVOK


Evoke Pharma Set to Gain 170%? This 5-Star Analyst Thinks So

Gastrointestinal disease-focused Evoke Pharma (EVOK) kicked off the week in style. Monday, June 22, saw shares go through the roof, and by the …

Evoke Pharma Pops 86% In Pre-Market On FDA Approval Of Gimoti Nasal Spray

Evoke Pharma (EVOK) shares leaped 86% in pre-market trading after the U.S.

Evoke Pharma Inc (EVOK) Shares Skyrocket as Gimoti Gets Closer to FDA Approval

Evoke Pharma Inc (NASDAQ:EVOK) investors have a smile on their faces Wednesday morning, after the drug maker announced that it has received a letter …

Company Update (NASDAQ:EVOK): Evoke Pharma Inc Announces Positive Non-Clinical Pre-NDA Meeting with FDA for Gimoti

Evoke Pharma Inc (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, today announced that it has completed a pre‑New Drug …

Evoke Pharma Provides Clinical Program Update For EVK-001

Evoke (NASDAQ:EVOK) issued a press release today to provide an update on its clinical program for EVK-001, a novel metoclopramide nasal spray for the relief of …

Evoke Pharma: The Stock Now Looks Even More Undervalued, Says Cantor Fitzgerald

In a research note published this morning, Cantor Fitzgerald analyst Irina Rivkind reiterated a Buy rating on Evoke Pharma (NASDAQ:EVOK) with a $20 …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts